<?xml version='1.0' encoding='UTF-8'?>
<Organism_Record>
  <Organism_ID>ASD03630000_1</Organism_ID>
  <Organism>Human</Organism>
  <Organism_Latin>Homo sapiens</Organism_Latin>
  <UniProt_ID>Q99497</UniProt_ID>
  <Seq_Length>189</Seq_Length>
  <Molecule_Weight>19891</Molecule_Weight>
  <KEGG_ID>hsa:11315</KEGG_ID>
  <Orthology_ID>K05687</Orthology_ID>
  <EBI_ID>EBI-1164361</EBI_ID>
  <Function_Summary>Protects cells against oxidative stress and cell death. Plays a role in regulating expression or stability of the mitochondrial uncoupling proteins SLC25A14 and SLC25A27 in dopaminergic neurons of the substantia nigra pars compacta and attenuates the oxidative stress induced by calcium entry into the neurons via L-type channels during pacemaking. Eliminates hydrogen peroxide and protects cells against hydrogen peroxide-induced cell death. May act as an atypical peroxiredoxin-like peroxidase that scavenges hydrogen peroxide. Following removal of a C-terminal peptide, displays protease activity and enhanced cytoprotective action against oxidative stress-induced apoptosis. Stabilizes NFE2L2 by preventing its association with KEAP1 and its subsequent ubiquitination. Binds to OTUD7B and inhibits its deubiquitinating activity. Enhances RELA nuclear translocation. Binds to a number of mRNAs containing multiple copies of GG or CC motifs and partially inhibits their translation but dissociates following oxidative stress. Required for correct mitochondrial morphology and function and for autophagy of dysfunctional mitochondria. Regulates astrocyte inflammatory responses. Acts as a positive regulator of androgen receptor-dependent transcription. Prevents aggregation of SNCA. Plays a role in fertilization. Has no proteolytic activity. Has cell-growth promoting activity and transforming activity. May function as a redox-sensitive chaperone.</Function_Summary>
  <Pfam_ID>PF01965:DJ-1_PfpI</Pfam_ID>
  <Allosteric_Activator_Count>0</Allosteric_Activator_Count>
  <Allosteric_Inhibitor_Count>1</Allosteric_Inhibitor_Count>
  <Allosteric_Regulator_Count>0</Allosteric_Regulator_Count>
  <Alias_List>
      <Alias>Parkingson disease protein 7</Alias>
      <Alias>DJ-1</Alias>
      <Alias>Oncogene DJ-1</Alias>
  </Alias_List>
  <Function_List>
    <Funtion>
      <Detail>Interacting selectively and non-covalently with pre-messenger RNA (pre-mRNA) or messenger RNA (mRNA).</Detail>
      <Keyword>MRNA binding</Keyword>
      <Ontology_ID>GO:0003729</Ontology_ID>
    </Funtion>
    <Funtion>
      <Detail>Catalysis of the hydrolysis of a peptide bond. A peptide bond is a covalent bond formed when the carbon atom from the carboxyl group of one amino acid shares electrons with the nitrogen atom from the amino group of a second amino acid.</Detail>
      <Keyword>Peptidase activity</Keyword>
      <Ontology_ID>GO:0008233</Ontology_ID>
    </Funtion>
    <Funtion>
      <Detail>Catalysis of the reaction: donor + hydrogen peroxide = oxidized donor + 2 H2O.</Detail>
      <Keyword>Peroxidase activity</Keyword>
      <Ontology_ID>GO:0004601</Ontology_ID>
    </Funtion>
    <Funtion>
      <Detail>Protein which is transiently involved in the noncovalent folding, assembly and/or disassembly of other polypeptides or RNA molecules, including any transport and oligomerisation processes they may undergo, and the refolding and reassembly of protein and RNA molecules denatured by stress. Though involved in these processes, chaperones are not an integral part of these functioning molecules. Also used for metallochaperones, which function to provide a metal directly to target proteins while protecting this metal from scavengers.</Detail>
      <Keyword>Chaperone</Keyword>
      <Ontology_ID>KW-0143</Ontology_ID>
    </Funtion>
    <Funtion>
      <Detail>Interacting selectively and non-covalently with an identical protein to form a homodimer.</Detail>
      <Keyword>Protein homodimerization activity</Keyword>
      <Ontology_ID>GO:0042803</Ontology_ID>
    </Funtion>
    <Funtion>
      <Detail>Interacting selectively and non-covalently with an RNA molecule or a portion thereof.</Detail>
      <Keyword>RNA binding</Keyword>
      <Ontology_ID>GO:0003723</Ontology_ID>
    </Funtion>
    <Funtion>
      <Detail>Catalysis of the hydrolysis of various bonds, e.g. C-O, C-N, C-C, phosphoric anhydride bonds, etc. Hydrolase is the systematic name for any enzyme of EC class 3.</Detail>
      <Keyword>Hydrolase activity</Keyword>
      <Ontology_ID>GO:0016787</Ontology_ID>
    </Funtion>
  </Function_List>
  <Mutation_List>
    <Muntion>
      <Position>64</Position>
      <Original>Glu</Original>
      <Variation>Asp</Variation>
    </Muntion>
    <Muntion>
      <Position>150</Position>
      <Original>Gly</Original>
      <Variation>Ser</Variation>
    </Muntion>
    <Muntion>
      <Position>149</Position>
      <Original>Asp</Original>
      <Variation>Ala</Variation>
    </Muntion>
    <Muntion>
      <Position>171</Position>
      <Original>Ala</Original>
      <Variation>Ser</Variation>
    </Muntion>
    <Muntion>
      <Position>163</Position>
      <Original>Glu</Original>
      <Variation>Lys</Variation>
    </Muntion>
    <Muntion>
      <Position>166</Position>
      <Original>Leu</Original>
      <Variation>Pro</Variation>
    </Muntion>
    <Muntion>
      <Position>26</Position>
      <Original>Met</Original>
      <Variation>Ile</Variation>
    </Muntion>
    <Muntion>
      <Position>98</Position>
      <Original>Arg</Original>
      <Variation>Gln</Variation>
    </Muntion>
    <Muntion>
      <Position>104</Position>
      <Original>Ala</Original>
      <Variation>Thr</Variation>
    </Muntion>
  </Mutation_List>
  <BioProcess_List>
    <BioProcess>
      <Detail>The immediate defensive reaction (by vertebrate tissue) to infection or injury caused by chemical or physical agents. The process is characterized by local vasodilation, extravasation of plasma into intercellular spaces and accumulation of white blood cells and macrophages.</Detail>
      <Keyword>Inflammatory response</Keyword>
      <Ontology_ID>GO:0006954</Ontology_ID>
    </BioProcess>
    <BioProcess>
      <Detail>A biological process that results in permanent cessation of all vital functions of a cell.</Detail>
      <Keyword>Cell death</Keyword>
      <Ontology_ID>GO:0008219</Ontology_ID>
    </BioProcess>
    <BioProcess>
      <Detail>Any process that modulates the rate, frequency, or extent of the androgen receptor signaling pathway.</Detail>
      <Keyword>Regulation of androgen receptor signaling pathway</Keyword>
      <Ontology_ID>GO:0060765</Ontology_ID>
    </BioProcess>
    <BioProcess>
      <Detail>The union of male and female gametes to form a zygote.</Detail>
      <Keyword>Single fertilization</Keyword>
      <Ontology_ID>GO:0007338</Ontology_ID>
    </BioProcess>
    <BioProcess>
      <Detail>Any process that stops, prevents, or reduces the frequency, rate or extent of protein binding.</Detail>
      <Keyword>Negative regulation of protein binding</Keyword>
      <Ontology_ID>GO:0032091</Ontology_ID>
    </BioProcess>
    <BioProcess>
      <Detail>A change in state or activity of a cell or an organism (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a disturbance in organismal or cellular homeostasis, usually, but not necessarily, exogenous (e.g. temperature, humidity, ionizing radiation).</Detail>
      <Keyword>Response to stress</Keyword>
      <Ontology_ID>GO:0006950</Ontology_ID>
    </BioProcess>
    <BioProcess>
      <Detail>A process that is carried out at the cellular level which results in the assembly, arrangement of constituent parts, or disassembly of a mitochondrion; includes mitochondrial morphogenesis and distribution, and replication of the mitochondrial genome as well as synthesis of new mitochondrial components.</Detail>
      <Keyword>Mitochondrion organization</Keyword>
      <Ontology_ID>GO:0007005</Ontology_ID>
    </BioProcess>
    <BioProcess>
      <Detail>A change in state or activity of a cell (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a hydrogen peroxide (H2O2) stimulus.</Detail>
      <Keyword>Cellular response to hydrogen peroxide</Keyword>
      <Ontology_ID>GO:0070301</Ontology_ID>
    </BioProcess>
    <BioProcess>
      <Detail>The hydrolysis of proteins into smaller polypeptides and/or amino acids by cleavage of their peptide bonds.</Detail>
      <Keyword>Proteolysis</Keyword>
      <Ontology_ID>GO:0006508</Ontology_ID>
    </BioProcess>
    <BioProcess>
      <Detail>Any process that modulates the occurrence or rate of cell death by apoptosis in the nervous system. It may stop or prevent or reduce the rate of cell death by apoptosis and it is activated by stress to counteract death signals in central nervous systems. Different neuroprotective mechanisms may be activated to combat distinct types of cellular stress, ERK pathway is one of several neuroprotective mechanisms and it is a model system to study neuronal apoptosis, which may contribute to several neurodegenerative diseases and aging-related neuron loss.</Detail>
      <Keyword>Neuroprotection</Keyword>
      <Ontology_ID>GO:0043526</Ontology_ID>
    </BioProcess>
    <BioProcess>
      <Detail>Any process involved in maintaining the structure and integrity of a protein and preventing it from degradation or aggregation.</Detail>
      <Keyword>Protein stabilization</Keyword>
      <Ontology_ID>GO:0050821</Ontology_ID>
    </BioProcess>
    <BioProcess>
      <Detail>Any process that modulates the frequency, rate or extent of the inflammatory response, the immediate defensive reaction (by vertebrate tissue) to infection or injury caused by chemical or physical agents.</Detail>
      <Keyword>Regulation of inflammatory response</Keyword>
      <Ontology_ID>GO:0050727</Ontology_ID>
    </BioProcess>
    <BioProcess>
      <Detail>Any process that decreases the rate or frequency of cell death. Cell death is the specific activation or halting of processes within a cell so that its vital functions markedly cease, rather than simply deteriorating gradually over time, which culminates in cell death.</Detail>
      <Keyword>Negative regulation of cell death</Keyword>
      <Ontology_ID>GO:0060548</Ontology_ID>
    </BioProcess>
    <BioProcess>
      <Detail>The process in which cells digest parts of their own cytoplasm; allows for both recycling of macromolecular constituents under conditions of cellular stress and remodeling the intracellular structure for cell differentiation.</Detail>
      <Keyword>Autophagy</Keyword>
      <Ontology_ID>GO:0006914</Ontology_ID>
    </BioProcess>
  </BioProcess_List>
  <PTM_List>
    <PTM>
      <Position>67</Position>
      <PTM_Type>Phosphotyrosine</PTM_Type>
    </PTM>
    <PTM>
      <Position>148</Position>
      <PTM_Type>N6-acetyllysine</PTM_Type>
    </PTM>
    <PTM>
      <Position>106</Position>
      <PTM_Type>Cysteine sulfinic acid (-SO2H)</PTM_Type>
    </PTM>
  </PTM_List>
  <Molecule_Seq>
    <Protein_Seq>MASKRALVILAKGAEEMETVIPVDVMRRAGIKVTVAGLAGKDPVQCSRDVVICPDASLEDAKKEGPYDVVVLPGGNLGAQNLSESAAVKEILKEQENRKGLIAAICAGPTALLAHEIGFGSKVTTHPLAKDKMMNGGHYTYSENRVEKDGLILTSRGPGTSFEFALAIVEALNGKEVAAQVKAPLVLKD</Protein_Seq>
    <DNA_Seq>ATAAAAATGGCTTCCAAAAGAGCTCTGGTCATCCTGGCTAAAGGAGCAGAGGAAATGGAGACGGTCATCCCTGTAGATGTCATGAGGCGAGCTGGGATTAAGGTCACCGTTGCAGGCCTGGCTGGAAAAGACCCAGTACAGTGTAGCCGTGATGTGGTCATTTGTCCTGATGCCAGCCTTGAAGATGCAAAAAAAGAGGGACCATATGATGTGGTGGTTCTACCAGGAGGTAATCTGGGCGCACAGAATTTATCTGAGTCTGCTGCTGTGAAGGAGATACTGAAGGAGCAGGAAAACCGGAAGGGCCTGATAGCCGCCATCTGTGCAGGTCCTACTGCTCTGTTGGCTCATGAAATAGGTTTTGGAAGTAAAGTTACAACACACCCTCTTGCTAAAGACAAAATGATGAATGGAGGTCATTACACCTACTCTGAGAATCGTGTGGAAAAAGACGGCCTGATTCTTACAAGCCGGGGGCCTGGGACCAGCTTCGAGTTTGCGCTTGCAATTGTTGAAGCCCTGAATGGCAAGGAGGTGGCGGCTCAAGTGAAGGCTCCACTTGTTCTTAAAGACTAGAGCAGCGAACTGCGACGATCACTTAGAGAAACAGGCCGTTAGGAATCCATTCTCACTGTGTTCGCTCTAAACAAAACAGTGGTAGGTTAATGTGTTCAGAAGTCGCTGTCCTTACTACTTTTGCGGAAGTATGGAAGTCACAACTACACAGAGATTTCTCAGCCTACAAATTGTGTCTATACATTTCTAAGCCTTGTTTGCAGAATAAACAGGGCATTTAGCAAACTAAAAAAAAAAAAAAAAAAA</DNA_Seq>
  </Molecule_Seq>
  <Tissuelocal_List>
    <TissueLocal>
      <TissueLocal>Skeletal muscle</TissueLocal>
    </TissueLocal>
    <TissueLocal>
      <TissueLocal>Heart</TissueLocal>
    </TissueLocal>
    <TissueLocal>
      <TissueLocal>Brain</TissueLocal>
    </TissueLocal>
    <TissueLocal>
      <TissueLocal>Placenta</TissueLocal>
    </TissueLocal>
    <TissueLocal>
      <TissueLocal>Kidney</TissueLocal>
    </TissueLocal>
    <TissueLocal>
      <TissueLocal>Testis</TissueLocal>
    </TissueLocal>
    <TissueLocal>
      <TissueLocal>Liver</TissueLocal>
    </TissueLocal>
    <TissueLocal>
      <TissueLocal>Pancreas</TissueLocal>
    </TissueLocal>
  </Tissuelocal_List>
  <CellLocal_List>
    <AsdMacromoleculeCelllocal>
        <CellLocal>Cytoplasm</CellLocal>
    </AsdMacromoleculeCelllocal>
    <AsdMacromoleculeCelllocal>
        <CellLocal>Nucleus</CellLocal>
    </AsdMacromoleculeCelllocal>
  </CellLocal_List>
  <Gene>
    <Gene_Name>PARK7</Gene_Name>
    <Gene_ID>11315</Gene_ID>
    <Genbank_ACCN>NM_001123377</Genbank_ACCN>
    <Protein_ACCN>NP_001116849</Protein_ACCN>
    <HGNC_ID>16369</HGNC_ID>
    <Gene_URL>http://www.ncbi.nlm.nih.gov/gene/11315</Gene_URL>
    <UCSC_ID>uc001aou.4</UCSC_ID>
    <EMBL_ID>ENSG00000116288</EMBL_ID>
  </Gene>
  <PPI_List>
    <PPI>
      <Uniprot_ID>Q9UER7</Uniprot_ID>
      <Gene_Name>DAXX</Gene_Name>
      <EBI_ID>EBI-77321</EBI_ID>
      <PPI_EBI_URL>EBI-1164361,EBI-77321</PPI_EBI_URL>
      <Experiment_Number>3</Experiment_Number>
    </PPI>
    <PPI>
      <Uniprot_ID>Q6GQQ9</Uniprot_ID>
      <Gene_Name>OTUD7B</Gene_Name>
      <EBI_ID>EBI-527784</EBI_ID>
      <PPI_EBI_URL>EBI-1164361,EBI-527784</PPI_EBI_URL>
      <Experiment_Number>3</Experiment_Number>
    </PPI>
    <PPI>
      <Uniprot_ID>O94776</Uniprot_ID>
      <Gene_Name>MTA2</Gene_Name>
      <EBI_ID>EBI-1783035</EBI_ID>
      <PPI_EBI_URL>EBI-1164361,EBI-1783035</PPI_EBI_URL>
      <Experiment_Number>3</Experiment_Number>
    </PPI>
    <PPI>
      <Uniprot_ID>P10275</Uniprot_ID>
      <Gene_Name>AR</Gene_Name>
      <EBI_ID>EBI-608057</EBI_ID>
      <PPI_EBI_URL>EBI-1164361,EBI-608057</PPI_EBI_URL>
      <Experiment_Number>6</Experiment_Number>
    </PPI>
    <PPI>
      <Uniprot_ID>Q13158</Uniprot_ID>
      <Gene_Name>FADD</Gene_Name>
      <EBI_ID>EBI-494804</EBI_ID>
      <PPI_EBI_URL>EBI-1164361,EBI-494804</PPI_EBI_URL>
      <Experiment_Number>9</Experiment_Number>
    </PPI>
  </PPI_List>
  <Disease_List>
    <Disease>
      <Disease_Name>Spinocerebellar Ataxia Type 17</Disease_Name>
      <Disease_Detail>Spinocerebellar Ataxia</Disease_Detail>
      <Disease_DB>SPN077</Disease_DB>
      <Disease_URL>http://www.malacards.org/card/spinocerebellar_ataxia_type_17?search=PARK7#related_genes</Disease_URL>
    </Disease>
    <Disease>
      <Disease_Name>Parkinson Disease 1</Disease_Name>
      <Disease_Detail>Parkinson's Disease</Disease_Detail>
      <Disease_DB>PRK031</Disease_DB>
      <Disease_URL>http://www.malacards.org/card/parkinson_disease_1?search=PARK7#related_genes</Disease_URL>
    </Disease>
    <Disease>
      <Disease_Name>Amyotrophic Lateral Sclerosis-Parkinsonism/dementia Complex</Disease_Name>
      <Disease_Detail>Amyotrophic Lateral Sclerosis</Disease_Detail>
      <Disease_DB>AMY066</Disease_DB>
      <Disease_URL>http://www.malacards.org/card/amyotrophic_lateral_sclerosis_parkinsonism_dementia_complex?search=PARK7#related_genes</Disease_URL>
    </Disease>
    <Disease>
      <Disease_Name>Parkinson Disease 7, Autosomal Recessive Early-Onset</Disease_Name>
      <Disease_Detail>Parkinson's Disease</Disease_Detail>
      <Disease_DB>PRK021</Disease_DB>
      <Disease_URL>http://www.malacards.org/card/parkinson_disease_7_autosomal_recessive_early_onset?search=PARK7#related_genes</Disease_URL>
    </Disease>
    <Disease>
      <Disease_Name>Parkinson's Disease</Disease_Name>
      <Disease_Detail>Parkinson's Disease</Disease_Detail>
      <Disease_DB>PRK002</Disease_DB>
      <Disease_URL>http://www.malacards.org/card/parkinsons_disease?search=PARK7#related_genes</Disease_URL>
    </Disease>
    <Disease>
      <Disease_Name>Park7-Related Parkinson Disease</Disease_Name>
      <Disease_Detail>Park7-Related Parkinson Disease</Disease_Detail>
      <Disease_DB>PRK015</Disease_DB>
      <Disease_URL>http://www.malacards.org/card/park7_related_parkinson_disease?search=PARK7#related_genes</Disease_URL>
    </Disease>
  </Disease_List>
  <PDB_List>
    <PDB>
      <PDB_Title>Structure of E163K/R145E DJ-1</PDB_Title>
      <PDB_ID>3B3A</PDB_ID>
      <Resolution>1.5</Resolution>
      <PDB_URL>http://www.pdb.org/pdb/explore/explore.do?structureId=3B3A</PDB_URL>
      <Has_Ligand>No</Has_Ligand>
      <PubMed_Title>Structural Impact of Three Parkinsonism-Associated Missense Mutations on Human DJ-1.</PubMed_Title>
      <Author>Lakshminarasimhan M, et al.</Author>
      <Journal>Biochemistry.2008 Feb 5;47(5):1381-92. Epub  2008 Jan 9.</Journal>
      <PubMed_ID>18181649</PubMed_ID>
    </PDB>
    <PDB>
      <PDB_Title>Crystal Structure of Human DJ-1</PDB_Title>
      <PDB_ID>1P5F</PDB_ID>
      <Resolution>1.1</Resolution>
      <PDB_URL>http://www.pdb.org/pdb/cgi/explore.cgi?pdbId=1P5F</PDB_URL>
      <Has_Ligand>No</Has_Ligand>
      <PubMed_Title>The 1.1-A resolution crystal structure of DJ-1, the protein mutated in autosomal recessive early onset Parkinson's disease.</PubMed_Title>
      <Author>Wilson MA, et al.</Author>
      <Journal>Proc Natl Acad Sci U S A. 2003 Aug 5;100(16):9111-3.</Journal>
      <PubMed_ID>12855764</PubMed_ID>
    </PDB>
    <PDB>
      <PDB_Title>Crystal Structure of E18D DJ-1</PDB_Title>
      <PDB_ID>3CZA</PDB_ID>
      <Resolution>1.2</Resolution>
      <PDB_URL>http://www.pdb.org/pdb/explore/explore.do?structureId=3CZA</PDB_URL>
      <Has_Ligand>No</Has_Ligand>
      <Ligand_Name>MALONIC ACID</Ligand_Name>
      <PubMed_Title>Cysteine pKa depression by a protonated glutamic acid in human DJ-1.</PubMed_Title>
      <Author>Witt AC, et al.</Author>
      <Journal>Biochemistry.2008 Jul 15;47(28):7430-40. Epub  2008 Jun 21.</Journal>
      <PubMed_ID>18570440</PubMed_ID>
    </PDB>
    <PDB>
      <PDB_Title>Crystal Structure of Human DJ-1</PDB_Title>
      <PDB_ID>1J42</PDB_ID>
      <Resolution>2.5</Resolution>
      <PDB_URL>http://www.pdb.org/pdb/explore/explore.do?structureId=1J42</PDB_URL>
      <Has_Ligand>No</Has_Ligand>
      <PubMed_Title>Crystal structures of human DJ-1 and Escherichia coli Hsp31, which share an evolutionarily conserved domain.</PubMed_Title>
      <Author>Lee SJ, et al.</Author>
      <Journal>J Biol Chem.2003 Nov 7;278(45):44552-9. Epub  2003 Aug 25.</Journal>
      <PubMed_ID>12939276</PubMed_ID>
    </PDB>
    <PDB>
      <PDB_Title>Crystal Structure of E18L DJ-1</PDB_Title>
      <PDB_ID>3CZ9</PDB_ID>
      <Resolution>1.15</Resolution>
      <PDB_URL>http://www.pdb.org/pdb/explore/explore.do?structureId=3CZ9</PDB_URL>
      <Has_Ligand>No</Has_Ligand>
      <Ligand_Name>O-ACETALDEHYDYL-HEXAETHYLENE GLYCOL</Ligand_Name>
      <PubMed_Title>Cysteine pKa depression by a protonated glutamic acid in human DJ-1.</PubMed_Title>
      <Author>Witt AC, et al.</Author>
      <Journal>Biochemistry.2008 Jul 15;47(28):7430-40. Epub  2008 Jun 21.</Journal>
      <PubMed_ID>18570440</PubMed_ID>
    </PDB>
    <PDB>
      <PDB_Title>Crystal structure of DJ-1/RS and implication on familial Parkinson's disease</PDB_Title>
      <PDB_ID>1Q2U</PDB_ID>
      <Resolution>1.6</Resolution>
      <PDB_URL>http://www.pdb.org/pdb/explore/explore.do?structureId=1Q2U</PDB_URL>
      <Has_Ligand>No</Has_Ligand>
      <PubMed_Title>Crystal structure of DJ-1/RS and implication on familial Parkinson's disease</PubMed_Title>
      <Author>Huai Q, et al.</Author>
      <Journal>FEBS Lett.2003 Aug 14;549(1-3):171-5.</Journal>
      <PubMed_ID>12914946</PubMed_ID>
    </PDB>
    <PDB>
      <PDB_Title>Crystal structure of aggregated form of DJ1</PDB_Title>
      <PDB_ID>3BWE</PDB_ID>
      <Resolution>2.4</Resolution>
      <PDB_URL>http://www.pdb.org/pdb/explore/explore.do?pdbId=3BWE</PDB_URL>
      <Has_Ligand>No</Has_Ligand>
      <PubMed_Title>Crystal structure of filamentous aggregates of human DJ-1 formed in an inorganic phosphate-dependent manner.</PubMed_Title>
      <Author>Cha SS, et al.</Author>
      <Journal>J Biol Chem. 2008 Dec 5;283(49):34069-75</Journal>
      <PubMed_ID>18922803</PubMed_ID>
    </PDB>
    <PDB>
      <PDB_Title>Pre-oxidation Complex of Human DJ-1</PDB_Title>
      <PDB_ID>2OR3</PDB_ID>
      <Resolution>1.2</Resolution>
      <PDB_URL>http://www.pdb.org/pdb/explore/explore.do?structureId=2OR3</PDB_URL>
      <Has_Ligand>No</Has_Ligand>
      <PubMed_Title>Cysteine pKa depression by a protonated glutamic acid in human DJ-1.</PubMed_Title>
      <Author>Witt AC, et al.</Author>
      <Journal>Biochemistry.2008 Jul 15;47(28):7430-40. Epub  2008 Jun 21.</Journal>
      <PubMed_ID>18570440</PubMed_ID>
    </PDB>
    <PDB>
      <PDB_Title>Crystal Structure of E18N DJ-1</PDB_Title>
      <PDB_ID>3CYF</PDB_ID>
      <Resolution>1.6</Resolution>
      <PDB_URL>http://www.pdb.org/pdb/explore/explore.do?structureId=3CYF</PDB_URL>
      <Has_Ligand>No</Has_Ligand>
      <PubMed_Title>Cysteine pKa depression by a protonated glutamic acid in human DJ-1.</PubMed_Title>
      <Author>Witt AC, et al.</Author>
      <Journal>Biochemistry.2008 Jul 15;47(28):7430-40. Epub  2008 Jun 21.</Journal>
      <PubMed_ID>18570440</PubMed_ID>
    </PDB>
    <PDB>
      <PDB_Title>Crystal structure of human DJ-1, P 31 2 1 space group</PDB_Title>
      <PDB_ID>1PDV</PDB_ID>
      <Resolution>1.8</Resolution>
      <PDB_URL>http://www.pdb.org/pdb/explore/explore.do?pdbId=1PDV</PDB_URL>
      <Has_Ligand>No</Has_Ligand>
      <PubMed_Title>Crystal structure of human DJ-1, a protein associated with early onset Parkinson's disease.</PubMed_Title>
      <Author>Tao X, et al.</Author>
      <Journal>J Biol Chem. 2003 Aug 15;278(33):31372-9</Journal>
      <PubMed_ID>12761214</PubMed_ID>
    </PDB>
    <PDB>
      <PDB_Title>The Crystal Structure of DJ-1, a Protein Related to Male Fertility and Parkinson's Disease</PDB_Title>
      <PDB_ID>1UCF</PDB_ID>
      <Resolution>1.95</Resolution>
      <PDB_URL>http://www.pdb.org/pdb/explore/explore.do?pdbId=1UCF</PDB_URL>
      <Has_Ligand>No</Has_Ligand>
      <PubMed_Title>The crystal structure of DJ-1, a protein related to male fertility and Parkinson's disease.</PubMed_Title>
      <Author>Honbou K, et al.</Author>
      <Journal>J Biol Chem. 2003 Aug 15;278(33):31380-4</Journal>
      <PubMed_ID>12796482</PubMed_ID>
    </PDB>
    <PDB>
      <PDB_Title>Crystal structure of E18D DJ-1 with oxidized C106</PDB_Title>
      <PDB_ID>3F71</PDB_ID>
      <Resolution>1.2</Resolution>
      <PDB_URL>http://www.pdb.org/pdb/explore/explore.do?structureId=3F71</PDB_URL>
      <Has_Ligand>No</Has_Ligand>
      <PubMed_Title>Formation of a Stabilized Cysteine Sulfinic Acid Is Critical for the Mitochondrial Function of the Parkinsonism Protein DJ-1.</PubMed_Title>
      <Author>Blackinton J, et al.</Author>
      <Journal>J Biol Chem.2009 Mar 6;284(10):6476-85. Epub  2009 Jan 5.</Journal>
      <PubMed_ID>19124468</PubMed_ID>
    </PDB>
    <PDB>
      <PDB_Title>Norepinephrine quinone conjugation to DJ-1</PDB_Title>
      <PDB_ID>2R1V</PDB_ID>
      <Resolution>1.7</Resolution>
      <PDB_URL>http://www.pdb.org/pdb/explore/explore.do?structureId=2R1V</PDB_URL>
      <Has_Ligand>No</Has_Ligand>
      <PubMed_Title>DJ-1 activation by catechol quinone conjugation</PubMed_Title>
    </PDB>
    <PDB>
      <PDB_Title>Structure of M26I DJ-1</PDB_Title>
      <PDB_ID>2RK4</PDB_ID>
      <Resolution>1.15</Resolution>
      <PDB_URL>http://www.pdb.org/pdb/explore/explore.do?pdbId=2RK4</PDB_URL>
      <Has_Ligand>No</Has_Ligand>
      <PubMed_Title>Structural impact of three Parkinsonism-associated missense mutations on human DJ-1.</PubMed_Title>
      <Author>Lakshminarasimhan M, et al.</Author>
      <Journal>Biochemistry. 2008 Feb 5;47(5):1381-92</Journal>
      <PubMed_ID>18181649</PubMed_ID>
    </PDB>
    <PDB>
      <PDB_Title>DJ-1 activation by catechol quinone modification</PDB_Title>
      <PDB_ID>2R1U</PDB_ID>
      <Resolution>1.5</Resolution>
      <PDB_URL>http://www.pdb.org/pdb/explore/explore.do?structureId=2R1U</PDB_URL>
      <Has_Ligand>No</Has_Ligand>
      <PubMed_Title>DJ-1 activation by catechol quinone modification</PubMed_Title>
    </PDB>
    <PDB>
      <PDB_Title>Crystal structure of the K130R mutant of human DJ-1</PDB_Title>
      <PDB_ID>1PE0</PDB_ID>
      <Resolution>1.7</Resolution>
      <PDB_URL>http://www.pdb.org/pdb/explore/explore.do?pdbId=1PE0</PDB_URL>
      <Has_Ligand>No</Has_Ligand>
      <PubMed_Title>Crystal structure of human DJ-1, a protein associated with early onset Parkinson's disease.</PubMed_Title>
      <Author>Tao X, et al.</Author>
      <Journal>J Biol Chem. 2003 Aug 15;278(33):31372-9</Journal>
      <PubMed_ID>12761214</PubMed_ID>
    </PDB>
    <PDB>
      <PDB_Title>Structure of E163K DJ-1</PDB_Title>
      <PDB_ID>2RK6</PDB_ID>
      <Resolution>1.15</Resolution>
      <PDB_URL>http://www.pdb.org/pdb/explore/explore.do?pdbId=2RK6</PDB_URL>
      <Has_Ligand>No</Has_Ligand>
      <PubMed_Title>Structural impact of three Parkinsonism-associated missense mutations on human DJ-1.</PubMed_Title>
      <Author>Lakshminarasimhan M, et al.</Author>
      <Journal>Biochemistry. 2008 Feb 5;47(5):1381-92</Journal>
      <PubMed_ID>18181649</PubMed_ID>
    </PDB>
    <PDB>
      <PDB_Title>Crystal structure of E18Q DJ-1 with oxidized C106</PDB_Title>
      <PDB_ID>3EZG</PDB_ID>
      <Resolution>1.15</Resolution>
      <PDB_URL>http://www.pdb.org/pdb/explore/explore.do?structureId=3EZG</PDB_URL>
      <Has_Ligand>No</Has_Ligand>
      <PubMed_Title>Formation of a Stabilized Cysteine Sulfinic Acid Is Critical for the Mitochondrial Function of the Parkinsonism Protein DJ-1.</PubMed_Title>
      <Author>Blackinton J, et al.</Author>
      <Journal>J Biol Chem.2009 Mar 6;284(10):6476-85. Epub  2009 Jan 5.</Journal>
      <PubMed_ID>19124468</PubMed_ID>
    </PDB>
    <PDB>
      <PDB_Title>Structure of A104V DJ-1</PDB_Title>
      <PDB_ID>3B38</PDB_ID>
      <Resolution>1.85</Resolution>
      <PDB_URL>http://www.pdb.org/pdb/explore/explore.do?structureId=3B38</PDB_URL>
      <Has_Ligand>No</Has_Ligand>
      <PubMed_Title>Structural Impact of Three Parkinsonism-Associated Missense Mutations on Human DJ-1.</PubMed_Title>
      <Author>Lakshminarasimhan M, et al.</Author>
      <Journal>Biochemistry.2008 Feb 5;47(5):1381-92. Epub  2008 Jan 9.</Journal>
      <PubMed_ID>18181649</PubMed_ID>
    </PDB>
    <PDB>
      <PDB_Title>Structure of A104T DJ-1</PDB_Title>
      <PDB_ID>2RK3</PDB_ID>
      <Resolution>1.05</Resolution>
      <PDB_URL>http://www.pdb.org/pdb/explore/explore.do?pdbId=2RK3</PDB_URL>
      <Has_Ligand>No</Has_Ligand>
      <PubMed_Title>Structural impact of three Parkinsonism-associated missense mutations on human DJ-1.</PubMed_Title>
      <Author>Lakshminarasimhan M, et al.</Author>
      <Journal>Biochemistry. 2008 Feb 5;47(5):1381-92</Journal>
      <PubMed_ID>18181649</PubMed_ID>
    </PDB>
    <PDB>
      <PDB_Title>Crystal Structure of E18Q DJ-1</PDB_Title>
      <PDB_ID>3CY6</PDB_ID>
      <Resolution>1.35</Resolution>
      <PDB_URL>http://www.pdb.org/pdb/explore/explore.do?structureId=3CY6</PDB_URL>
      <Has_Ligand>No</Has_Ligand>
      <PubMed_Title>Cysteine pKa depression by a protonated glutamic acid in human DJ-1.</PubMed_Title>
      <Author>Witt AC, et al.</Author>
      <Journal>Biochemistry.2008 Jul 15;47(28):7430-40. Epub  2008 Jun 21.</Journal>
      <PubMed_ID>18570440</PubMed_ID>
    </PDB>
    <PDB>
      <PDB_Title>Crystal structure of human DJ-1, P 1 21 1 space group</PDB_Title>
      <PDB_ID>1PDW</PDB_ID>
      <Resolution>2.2</Resolution>
      <PDB_URL>http://www.pdb.org/pdb/explore/explore.do?structureId=1PDW</PDB_URL>
      <Has_Ligand>No</Has_Ligand>
      <PubMed_Title>Crystal Structure of Human DJ-1, a Protein Associated with Early Onset Parkinson's Disease.</PubMed_Title>
      <Author>Tao X, et al.</Author>
      <Journal>J Biol Chem.2003 Aug 15;278(33):31372-9. Epub  2003 May 21.</Journal>
      <PubMed_ID>12761214</PubMed_ID>
    </PDB>
    <PDB>
      <PDB_Title>dopamine quinone conjugation to DJ-1</PDB_Title>
      <PDB_ID>2R1T</PDB_ID>
      <Resolution>1.7</Resolution>
      <PDB_URL>http://www.pdb.org/pdb/explore/explore.do?structureId=2R1T</PDB_URL>
      <Has_Ligand>No</Has_Ligand>
      <PubMed_Title>DJ-1 is a proisopeptidase</PubMed_Title>
    </PDB>
    <PDB>
      <PDB_Title>Human DJ-1 with sulfinic acid</PDB_Title>
      <PDB_ID>1SOA</PDB_ID>
      <Resolution>1.2</Resolution>
      <PDB_URL>http://www.pdb.org/pdb/explore/explore.do?structureId=1SOA</PDB_URL>
      <Has_Ligand>No</Has_Ligand>
      <PubMed_Title>The Parkinson's disease protein DJ-1 is neuroprotective due to cysteine-sulfinic acid-driven mitochondrial localization.</PubMed_Title>
      <Author>Canet-Aviles RM,  et al.</Author>
      <Journal>(2004) Proc.Natl.Acad.Sci.USA 101: 9103-9108</Journal>
      <PubMed_ID>15181200</PubMed_ID>
    </PDB>
    <PDB>
      <PDB_Title>Structure of M26L DJ-1</PDB_Title>
      <PDB_ID>3B36</PDB_ID>
      <Resolution>1.5</Resolution>
      <PDB_URL>http://www.pdb.org/pdb/explore/explore.do?structureId=3B36</PDB_URL>
      <Has_Ligand>No</Has_Ligand>
      <PubMed_Title>Structural Impact of Three Parkinsonism-Associated Missense Mutations on Human DJ-1.</PubMed_Title>
      <Author>Lakshminarasimhan M, et al.</Author>
      <Journal>Biochemistry.2008 Feb 5;47(5):1381-92. Epub  2008 Jan 9.</Journal>
      <PubMed_ID>18181649</PubMed_ID>
    </PDB>
  </PDB_List>
  <Network_List>
    <Network>
      <Pathway_ID>ko05012</Pathway_ID>
      <Pathway_Title>Parkinson's disease</Pathway_Title>
      <Pathway_Class>Human Diseases</Pathway_Class>
      <Pathway_Subclass>Neurodegenerative diseases</Pathway_Subclass>
    </Network>
  </Network_List>
  <Fold>
    <SCOP_Class>Alpha and beta proteins (a/b)</SCOP_Class>
    <SCOP_URL>http://scop.mrc-lmb.cam.ac.uk/scop/data/scop.b.d.ch.bf.d.d.html</SCOP_URL>
    <CATH_Class>Mixed alpha-beta</CATH_Class>
    <CATH_URL>http://www.cathdb.info/pdb/1j42</CATH_URL>
  </Fold>
  <Modulator_List>
    <Modulator>
      <ASD_ID>ASD03630001</ASD_ID>
      <Modulator_Feature>Inhibitor</Modulator_Feature>
    </Modulator>
  </Modulator_List>
  <Create_Date>2012-05-31</Create_Date>
</Organism_Record>